Abstract:Objective To observe the positive rate of anti-cyclic citrullinated peptides antibody (anti-CCP antibody) in patients with rheumatoid arthritis (RA) associated interstitial lung disease (RA-ILD) and its correlation with indicators of ILD clinical, imaging and laboratory in order to explore the role of anti-CCP antibodies in the pathogenesis of RA-ILD. Method The clinical data and auxiliary examination (including lung imaging, lung function, blood gas and other RA related laboratory indicators) of 98 RA patients in our hospital from January 2017 to September 2018 were retrospectively collected. According to whether the patient with ILD, they were divided into RA-ILD group (50 cases) and RA without ILD group (48 cases). The differences of serum anti-CCP antibody expression between two groups and the correlation between the anti-CCP antibody and the ILD related score in the RA-ILD group were analyzed. Results The positive rate of anti-CCP antibody in RA-ILD was 76.0%, which is higher than it in RA without ILD (P?0.05); the number of joint swelling in RA-ILD group was more than that in RA-non ILD group (P 0.05), but there was no significant difference in joint pain and morning stiffness between two groups (P?>?0.05); there was no significant correlation between anti-CCP antibody level and DSA28 score in RA-ILD patients (P?>?0.05); there was no significant correlation between the anti-CCP antibody titer and the Clinical-Radiographic-Physiologic (CRP) score, lung function and oxygen partial pressure associated with ILD in patients with RA-ILD (P?>?0.05). Conclusion Anti-CCP antibody is involved in the pathogenesis of RA-ILD and is expected to be a predictor of RA-ILD.